Giant Cell Arteritis and Takayasu Arteritis: Clinical Aspects, Diagnostics and Therapy

被引:0
作者
Wagner, A. D. [1 ]
Schmidt, W. A. [2 ]
机构
[1] Hannover Med Sch, Dept Nephrol, Hannover, Germany
[2] Immanuel Krankenhaus Berlin, Rheumaklin Berlin Buch, Berlin, Germany
关键词
temporal arteritis; Takayasu arteritis; polymyalgia rheumatica; ultrasound; glucocorticoids; RHEUMATOLOGY; 1990; CRITERIA; LARGE-VESSEL VASCULITIS; TEMPORAL ARTERITIS; POLYMYALGIA-RHEUMATICA; DISEASE-ACTIVITY; LUPUS NEPHRITIS; FOLLOW-UP; ULTRASONOGRAPHY; CLASSIFICATION; ANGIOGRAPHY;
D O I
10.1055/s-0033-1358391
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Giant cell arteritis (GCA) is the most common systemic vasculitis and affects large and medium-sized vessels. Takayasu arteritis (TA) is the second vasculitis of the large-sized vessels and affects young adults under 40 years of age. TA is the third most common vasculitis in children. Both vasculitides can cause ischaemic complications of extremities and visceral organs. The most common complication of GCA is ischaemia of the optic nerve causing irreversible blindness. Besides, dissection of aortic aneurysms, cerebral ischaemia, ischaemia of limbs or organs as well as tongue necrosis may occur. Diagnosis shoud be confirmed by biopsy or sonography but diagnostic procedures shoud not delay therapy. In addition, angiography is important as a diagnostic procedure in TA. In both large-sized vasculitides magnetic resonance angiography, computed tomography angiography, positron emission tomography and last but not least colour Dopler ultrasonography enable early diagnosis and the monitoring of responses to treatment. Corticosteroids are the therapy of choice in the treatment of GCA and TA. Disease-modifying drugs particularly methotrexate have a corticosteroid sparing effect in GCA. In contrast, TNF-blocking agents are effective in the treatment of TA.
引用
收藏
页码:280 / 287
页数:8
相关论文
共 60 条
[51]   Does this patient have temporal arteritis? [J].
Smetana, GW ;
Shmerling, RH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (01) :92-101
[52]   Echocardiographic follow-up of patients with Takayasu's arteritis: Five-year survival [J].
Soto, ME ;
Espinola-Zavaleta, N ;
Ramirez-Quito, O ;
Reyes, PA .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2006, 23 (05) :353-360
[53]  
STRACHAN RW, 1964, Q J MED, V33, P57
[54]   Utility and limitations of magnetic resonance imaging in diagnosis and treatment [J].
Tso, E ;
Flamm, SD ;
White, RD ;
Schvartzman, PR ;
Mascha, E ;
Hoffman, GS .
ARTHRITIS AND RHEUMATISM, 2002, 46 (06) :1634-1642
[55]   Pathology of Takayasu arteritis: A brief review [J].
Vaideeswar, Pradeep ;
Deshpande, Jaya R. .
ANNALS OF PEDIATRIC CARDIOLOGY, 2013, 6 (01) :52-58
[56]   AA amyloidosis in Takayasu's arteritis - long-term survival on maintenance haemodialysis [J].
Wada, Y ;
Nishida, H ;
Kohno, K ;
Tamai, O ;
Fujisawa, M ;
Katoh, S ;
Morimatsu, M ;
Okuda, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (10) :2478-2481
[57]   The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis [J].
Webb, M ;
Chambers, A ;
AL-Nahhas, A ;
Mason, JC ;
Maudlin, L ;
Rahman, L ;
Frank, J .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (05) :627-634
[58]   Pediatric Vasculitis [J].
Weiss, Pamela F. .
PEDIATRIC CLINICS OF NORTH AMERICA, 2012, 59 (02) :407-+
[59]  
Yamada I, 2000, JMRI-J MAGN RESON IM, V11, P481, DOI 10.1002/(SICI)1522-2586(200005)11:5<481::AID-JMRI3>3.0.CO
[60]  
2-4